Jeff Abraham

Jeff Abraham co-leads the Digital Health and Health IT Practice at Health Advances. His nearly 20-year career in healthcare spans digital health and therapeutics, MedTech, biopharma, and healthcare services. He holds extensive expertise related to digital health go-to market strategy commercialization, global market access, product development, and evidence generation.

Jeff currently serves as a Task Group Lead for the National Council of Prescription Drug Programs, a Task Group Lead for the Digital Therapeutics Alliance, representative on the Founding Members Council for the Digital Medicine Society, and other advisory roles for payer organizations and professional societies.

Prior to joining Health Advances, Jeff held executive roles in market access, trade, and commercial functions at Akili Interactive, an industry leading digital therapeutics company. During his time at Akil Interactive, Jeff focused on payer strategy, marketing, sales, reimbursement, pricing, strategic partnerships, evidence generation, distribution, launch planning and execution. Before Akili Interactive, Jeff was Senior Director for the Medicines Company in their Value Development department. He supported commercialization and global launch of novel drug device combo and the development of additional perioperative and cardiovascular products. Before The Medicines Company, Jeff was a consultant for GfK working in global market access and commercialization. His work spanned numerous therapeutic areas across drug, devices, and diagnostics. Jeff holds a Master of Science in Physical Therapy and an MBA with a specialization in Health Sector Management from Boston University.